Novel Antineuronal Antibodies in Gastrointestinal Motility Disorders

Overview

About this study

The purpose of this study is to identify novel anti neuronal antibodies that contribute to autoimmune gastrointestinal motility disorders by analyzing the serum of patients with abnormal gastrointestinal motility.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- Males and females >13 years old.

- Patient referred to the GI Motility clinic for suspected enteric dysmotility based on
chronic refractory gastrointestinal symptoms

- English proficiency and literacy sufficient to sign consent.

Exclusion Criteria:

- Pregnancy documented with a serum or urine pregnancy test. If participants believe
that they are pregnant, they will need to notify a study physician who will order a
serum or urine test for pregnancy and remove them from the study if the test results
come back positive.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 2/6/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Pankaj Pasricha, M.B.B.S., M.D.	Open for enrollment	Contact information: Guillermo Barahona Hernandez (410) 603-8343 Barahona.Guillermo@mayo.edu

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Pankaj Pasricha, M.B.B.S., M.D.

Open for enrollment

Contact information:

Guillermo Barahona Hernandez

(410) 603-8343

Barahona.Guillermo@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials